Search

Your search keyword '"Isabel Figueroa"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Isabel Figueroa" Remove constraint Author: "Isabel Figueroa"
101 results on '"Isabel Figueroa"'

Search Results

1. A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins

2. Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection

3. Production, Marketing, Sustainability, and Price Forecast of Potato in the Gran Mercado Mayorista de Lima - Peru

4. Conocimiento declarativo, procedimental y metacognitivo en instancias orales de estudiantes de ELE

6. Anti–Lymphocyte Antigen 6 Complex, Locus E-Seco-Cyclopropabenzindol-4-One-Dimer Antibody-Drug Conjugate That Forms Adduct withα1-Microglobulin Demonstrates Slower Systemic Antibody Clearance and Reduced Tumor Distribution in Animals

7. Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy

8. Contributors

13. Latitudinal Variation in the Toxicity and Sexual Compatibility of Alexandrium catenella Strains From Southern Chile

14. Direct evidende of sex and a hypothesis about meiosis in Symbiodiniaceae

15. Impacts of harmful algal blooms on the aquaculture industry: Chile as a case study

16. Aprovechamiento del estiércol de alpaca e ichu para la producción de briquetas como fuente de energía calorífica en Arequipa

17. Direct Evidence Of Sex In Symbiodiniaceae And A Hypothesis About Meiosis

18. The 5S rRNA genes in Alexandrium: their use as a FISH chromosomal marker in studies of the diversity, cell cycle and sexuality of dinoflagellates

19. Morphological and phylogenetic data do not support the split of Alexandrium into four genera

20. Anti-Lymphocyte Antigen 6 Complex, Locus E

21. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging

22. Preclinical pharmacokinetics and pharmacodynamics of DCLL9718A: An antibody-drug conjugate for the treatment of acute myeloid leukemia

23. Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody–Drug Conjugates

24. Species diversity and abundance of dinoflagellate resting cysts seven months after a bloom of Alexandrium catenella in two contrasting coastal systems of the Chilean Inland Sea

25. Prediction of non-linear pharmacokinetics in humans of an antibody-drug conjugate (ADC) when evaluation of higher doses in animals is limited by tolerability: Case study with an anti-CD33 ADC

26. Temperature-dependent growth and sexuality of the ciguatoxin producer dinoflagellate Gambierdiscus spp. in cultures established from the Canary Islands

27. Drivers of dinoflagellate benthic cyst assemblages in the NW Patagonian Fjords System and its adjacent oceanic shelf, with a focus on harmful species

28. A quantitative systems pharmacology consortium approach to managing immunogenicity of therapeutic proteins

29. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity

30. Confirmation of the wide host range of Parvilucifera corolla (Alveolata, Perkinsozoa)

31. Alexandrium catenella cyst accumulation by passive and active dispersal agents: Implications for the potential spreading risk in Chilean Patagonian fjords

32. Chromosomal markers in the genus Karenia: Towards an understanding of the evolution of the chromosomes, life cycle patterns and phylogenetic relationships in dinoflagellates

33. Scrippsiella acuminata versus Scrippsiella ramonii: A Physiological Comparison

34. Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology

35. Development of Anti-CD74 Antibody-Drug Conjugates to Target Glucocorticoids to Immune Cells

36. Stimulus-Response Mechanisms: An Overview

37. Evaluation of Tumor Growth Inhibition in Preclinical Tumor Models: A Quantitative Approach

38. Life histories of microalgal species causing harmful blooms: Haploids, diploids and the relevance of benthic stages

39. Antibody Drug Conjugates: Translational Considerations

40. Nuclear and Cell Morphological Changes during the Cell Cycle and Growth of the Toxic Dinoflagellate Alexandrium minutum

42. The life history of the toxic marine dinoflagellate Protoceratium reticulatum (Gonyaulacales) in culture

43. Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020)

44. The potential for arms race and Red Queen coevolution in a protist host–parasite system

45. Model-Based Scale-up and Design Space Determination for a Batch Reactive Distillation with a Dean–Stark Trap

46. Parvilucifera sinerae (Alveolata, Myzozoa) is a Generalist Parasitoid of Dinoflagellates

47. Life-cycle, ultrastructure, and phylogeny of Parvilucifera corolla sp. nov. (Alveolata, Perkinsozoa), a parasitoid of dinoflagellates

48. 'Canary Islands (NE Atlantic) as a biodiversity ‘hotspot’ of Gambierdiscus: Implications for future trends of ciguatera in the area'

49. CELL CYCLE AND CELL MORTALITY OF ALEXANDRIUM MINUTUM (DINOPHYCEAE) UNDER SMALL-SCALE TURBULENCE CONDITIONS(1)

50. INTERACTIVE EFFECTS OF SALINITY AND TEMPERATURE ON PLANOZYGOTE AND CYST FORMATION OF ALEXANDRIUM MINUTUM (DINOPHYCEAE) IN CULTURE(1)

Catalog

Books, media, physical & digital resources